Informatie:
Fout:
ID
19018
Beschrijving
Effects of GCP on Prostate Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00269555
Link
https://clinicaltrials.gov/show/NCT00269555
Trefwoorden
Versies (1)
- 30-11-16 30-11-16 -
Geüploaded op
30 november 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Prostate Cancer NCT00269555
Eligibility Prostate Cancer NCT00269555
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00269555
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Gender | Prostate carcinoma
Item
participants must be male and have a pathological diagnosis of prostate cancer.
boolean
C0079399 (UMLS CUI [1])
C0600139 (UMLS CUI [2])
C0600139 (UMLS CUI [2])
Therapeutic procedure | Operative Surgical Procedures | Radical retropubic prostatectomy | Therapeutic radiology procedure | Hormone Therapy
Item
no treatment (surgery [rrp], radiation, or hormones) prior to study entry.
boolean
C0087111 (UMLS CUI [1])
C0543467 (UMLS CUI [2])
C0194825 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
C0543467 (UMLS CUI [2])
C0194825 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
Patient Decision | Operative Surgical Procedures | Radical retropubic prostatectomy | Therapeutic radiology procedure | Hormone Therapy
Item
the patient has decided, after consultation with his own doctor, to have no treatment intervention (surgery [rrp], radiation, or hormones) for the next six months.
boolean
C0030705 (UMLS CUI [1,1])
C0679006 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2])
C0194825 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
C0679006 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2])
C0194825 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
Prostate specific antigen measurement
Item
psa between 2.0 and 10.0 ng/ml.
boolean
C0201544 (UMLS CUI [1])
Raised prostate specific antigen | Patient Surveillance Duration
Item
if psa is >10.0, patient must have been on active surveillance for 12 months prior to study initiation.
boolean
C0178415 (UMLS CUI [1])
C0030705 (UMLS CUI [2,1])
C0038842 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
C0030705 (UMLS CUI [2,1])
C0038842 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
Allergy to soy | Hypersensitivity Soy product
Item
no known allergy to soy or soy products.
boolean
C4075590 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
Genistein Unit per Gram per Day Dietary Supplements
Item
the patient is not currently taking more than 2 grams of genistein a day in nutritional or diet enhancing supplements (otc supplements).
boolean
C0061202 (UMLS CUI [1,1])
C2349072 (UMLS CUI [1,2])
C0242295 (UMLS CUI [1,3])
C2349072 (UMLS CUI [1,2])
C0242295 (UMLS CUI [1,3])
Prostate carcinoma
Item
no pathological documentation of prostate cancer.
boolean
C0600139 (UMLS CUI [1])
Allergy to soy | Hypersensitivity Soy product
Item
allergy to soy or soy products
boolean
C4075590 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
Therapeutic procedure Prostate carcinoma
Item
prior history of treatment for prostate cancer.
boolean
C0087111 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,2])